Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 9/8/2025CDE Invites Feedback on Draft Guidelines for Clinical Trials of Target...
  • 9/8/2025CDE Seeks Comments on Draft Guidelines for Clinical Trials of Anti-Fib...
  • 9/8/2025CDE Solicits Comments on Draft Guidelines for Type I Meetings on Advan...
  • 9/8/2025CDE Opens Public Consultation on Draft Guidelines for Type I Meetings ...
  • 9/8/2025CDE Seeks Comments on Draft Technical Guidelines for Chemically Synthe...
  • 9/8/2025CDE Issues Guidance on Evaluating pH-Dependent Drug Interactions for O...
  • 9/8/2025CDE Issues Guidance on Evaluating pH-Dependent Drug Interactions for O...
  • 9/8/2025CDE Issues Technical Guidelines for Clinical Pharmacology Research on ...
  • 9/8/2025NMPA Solicits Comments on Draft Guidelines for Online Prescription Dru...
  • 9/8/2025Junshi Achieves Positive Phase 3 Results for JS005 in Psoriasis Treatm...
  • 9/8/2025Innovent's Tigulixostat Demonstrates Superior Efficacy in Phase 2 Gout...
  • 9/8/2025Atom Thera Achieves Positive Phase 2b/3 Trial Results for Lingdolinura...
  • 9/8/2025Baili and BMS Present Promising Data on EGFR/HER3 Bispecific ADC for F...
  • 9/8/2025Avadel Partners with XWPharma to Advance Valiloxybate for Sleep Disord...
  • 9/8/2025Epigenic Secures $60M in Series B Financing to Advance Epigenetic Drug...
  • 9/5/2025Hengrui Licenses Myosin Inhibitor HRS-1893 to U.S. Startup Braveheart ...
  • 9/5/2025Yangtze River's Fexuprazan Gains Chinese Approval
  • 9/5/20253SBio Secures IND Nod for Dual-Target CAR-T Therapy SA102
  • 9/5/2025BioNTech and DualityBio Score Phase III Win with Promising ADC in Brea...
  • 9/4/2025CDE Seeks Comments on Draft Guidelines for Pan-Cancer Drug Development
  • 9/4/2025iRegene Raises Series B+ to Advance Parkinson's and Ophthalmology Cell...
  • 9/4/2025Baili-Bio Launches Phase 3 Trial for HER2-Targeted ADC in Gastric Canc...
  • 9/3/2025Aon Report Highlights Rapid Growth and Challenges in China's Health In...
  • 9/3/2025Ab&B Bio-Tech Gains Approval for First Quadrivalent Subunit Influenza ...
  • 9/3/2025China to Become World's Third-Largest Innovative Drug Market by 2028:...
  • 9/3/2025E-nitiate Biopharma Secures ~¥200M in Series B Funding to Advance Au...
  • 9/3/2025Sanofi China Receives Approval for Tzield to Delay Progression of Type...
  • 9/3/2025Argo Biopharma Strikes $5.2B Cardiovascular Collaboration with Novarti...
  • 9/3/2025China Biopharma Sees $320M Upfronts and $8.5B Milestones in H1 2025 Li...
  • 9/3/2025Global Pharma Firms Pour $48 Billion into China in H1 2025, IQVIA Repo...
  • Page:2/58 Total number of articles:1735: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group